Information:
Fel:
Nyckelord
- Clinical Trial (11)
- Breast Neoplasms (10)
- Follow-Up Studies (6)
- Registries (3)
- On-Study Form (3)
- COVID-19 (3)
- Palliative Care (3)
- Baseline (2)
- Cost of Illness (1)
- Case Management (1)
- Casearia (1)
- Carcinoma (1)
- Off-Treatment (1)
- Routine documentation (1)
- Eligibility Determination (1)
- Ethics (1)
- Fuchs' Endothelial Dystrophy (1)
- Head and Neck Neoplasms (1)
- Neoplasm Staging (1)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
17 Sökresultat.
Item-grupper: CRF Header, Head & Neck: Form Administration, Head & Neck: Patient Assessment, Head & Neck: Disease Description - Initial Diagnosis of Disease, Head & Neck: Disease Description - Current Diagnosis, Head & Neck: Prior Health History - Palliative, Head & Neck: Prior Treatment - Systemic Therapy, Head & Neck: Prior Treatment - Radiation Therapy, Head & Neck: Prior Treatment - Surgery
Item-grupper: Header Module, Header, Amended Data, Patient Characteristics, Disease Description, Treatment Plan, Circulating Tumor Cell (CTC) Enumeration, Comments
Item-grupper: Header Module, Header, Amended Data, Pre-Registration Evaluation, Disease Description, Metastatic Site(s) of Involvement (At Study Entry), STATUS OF LOCAL-REGIONAL DISEASE - Prior to initiation of Optimal Systemic Therapy, Breast Involvement, Comments
Item-grupper: Header Module, Header, Amended Data, Report Period, Section I - Vital Status, Section II - Reporting Period, Status of Local-Regional Disease, CHEST WALL, Breast Involvement, Section IV - Status of Distant Disease, Circulating Tumor Cell (CTC) Enumeration, Comments
Item-grupper: General information, Surgery, Footer Module
Item-grupper: ECOG clinical trial administrative data, Data amendment, Report Period, Section II - Reporting Period, Section 1 - Vital Status, Footer Module
Item-grupper: Header Module, Header, Amended Data, Vital Status, Section I, Comments
Item-grupper: ECOG clinical trial administrative data, Report Period, Data amendment, Section II - Reporting Period, Section 1 - Vital Status, Therapy Administered - Chemotherapy, Therapy Administered - Hormone therapy, Therapy Administered - New Progression, Footer Module
Item-grupper: ECOG clinical trial administrative data, Data amendment, Section II - Reporting Period, Section 1 - Vital Status, Footer Module
Item-grupper: ECOG clinical trial administrative data, Data amendment, ON TREATMENT, Disease Assessment, TARGET LESIONS - NON-NODAL, TARGET LESIONS - NODAL, NONTARGET LESIONS, New Lesions, Overall Response per RECIST Criteria - Target, Nontarget and New Lesions, Symptomatic Deterioration, Footer Module
Item-grupper: Header Module, Header, Amended Data, TARGET LESIONS, TARGET LESIONS - NON NODAL, TARGET LESIONS - NODAL, NONTARGET LESIONS, Footer Module
Item-grupper: Reasons for change of therapeutic goals from life-prolonging to palliative, Ethics consultation, Patient declined life-prolonging measures in case of life threatening diseases, Specialist palliative care setting, Specialist palliative care type, Specialist palliative care professionals involved, Drugs prescribed for symptom control (e.g. breathlessness, pain, death rattle), Is data entry for this section finished?